26 May, 2017
The stock has a beta value of 1.62. Eam Invsts Limited Company reported 243,938 shares. Gabelli Securities Inc who had been investing in Corcept Therapeutics Inc Oc for a number of months, seems to be less bullish one the $1.35B market cap company. About 765,551 shares traded. It has outperformed by 108.11% the S&P500. Insiders sold 4,119,955 shares of company stock valued at $38,110,853 in the last quarter. This rating uses a scale from 1 to 5. About shares traded. athenahealth, Inc (NDAQ:ATHN) has risen 0.90% since May 24, 2016 and is uptrending. Exxon Mobil Corporation (NYSE:XOM) has declined 9.08% since May 25, 2016 and is downtrending. It has underperformed by 16.38% the S&P500. Analysts taken into consideration by Zacks Research have a current mean target price of $11 on Corcept Therapeutics Incorporated (NASDAQ:CORT) shares.
Investors sentiment decreased to 1.86 in Q4 2016. CORT's value Change from Open was at 2.36% with a Gap of -0.08%. 36 funds opened positions while 44 raised stakes. Numeric Limited Liability Co has invested 0.02% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT).
The stock of Corcept Therapeutics Incorporated (NASDAQ:CORT) is a huge mover today! Panagora Asset holds 0% or 47,032 shares in its portfolio. Blackrock Institutional Co Na, California-based fund reported 2.15M shares. Fuller & Thaler Asset Mgmt Incorporated stated it has 0% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT).
Ingalls & Snyder Llc increased Methanex Corp (NASDAQ:MEOH) stake by 14,842 shares to 236,926 valued at $10.38 million in 2016Q4. Barclays Public Ltd Com accumulated 99,000 shares or 0% of the stock. Its up 8.31% from 4.90M shares previously. Annual earnings per share (EPS) growth was at 16.90% in past 5 Years and Long-term annual earnings per share (EPS) growth is projected to achieve 54.20% in coming 5 years. 148,462 are owned by Millennium Management Lc. It fall, as 14 investors sold Corcept Therapeutics Incorporated shares while 29 reduced holdings. Alambic Investment Management L.P. boosted its stake in shares of Corcept Therapeutics by 67.5% in the third quarter.
Analysts await Corcept Therapeutics Incorporated (NASDAQ:CORT) to report earnings on August, 1. This translates into $6.77M profit for CORT giving the stock a 51.67 P/E. The company is expecting to attain earnings per share (EPS) growth of 216.90% in this year and the earnings per share (EPS) growth estimated to be 95.06% in the next year. Guggenheim Capital owns 26,588 shares or 0% of their United States portfolio. Zooming out to the 200-day moving average, shares have been seen trading 45.70% away from that value. Corcept Therapeutics has a 12-month low of $4.95 and a 12-month high of $12.40.
Investors sentiment decreased to 0.83 in 2016 Q4. Its up 0.68, from 1.02 in 2016Q3. It dived, as 58 investors sold XOM shares while 851 reduced holdings. Quantitative Systematic Strategies Ltd Liability reported 23,015 shares. Strategic Wealth Advsr Gp Limited Liability Com invested in 209,882 shares or 3.07% of the stock. Allianz Asset Mngmt Ag invested in 139,113 shares. Cincinnati Com has invested 3.79% in Exxon Mobil Corporation (NYSE:XOM). Northern Trust invested in 1.05 million shares. Pioneer Management Inc reported 199,200 shares. Volume on the day was 1.21 million shares. New York-based Cohen & Steers has invested 0.02% in Exxon Mobil Corporation (NYSE:XOM). California State Teachers Retirement has invested 0.01% in Rexford Industrial Realty Inc (NYSE:REXR). 11,999 are held by Proshare Ltd Liability. A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range. Therefore 100% are positive. Rexford Industrial had 13 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Capital One with "Overweight" on Monday, November 2. The rating was upgraded by Bank of America on Thursday, May 11 to "Buy". The company has market cap of $5.39 billion. Cantor Fitzgerald maintained the shares of ATHN in report on Friday, April 28 with "Buy" rating. Analysts set a 12-month price target of $2.33 a share. Schleckser Robert N sold $496,990 worth of Exxon Mobil Corporation (NYSE:XOM) on Monday, December 5. 8,220 shares valued at $719,817 were sold by Rosenthal David S on Wednesday, December 7. The insider ENRIGHT PATRICK G sold $1.67 million. Following the transaction, the director now directly owns 204,210 shares in the company, valued at $1,991,047.50. Kcg Holdings reported 0.01% of its portfolio in athenahealth, Inc (NASDAQ:ATHN).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
